1. Home
  2. CLSD vs BZFD Comparison

CLSD vs BZFD Comparison

Compare CLSD & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • BZFD
  • Stock Information
  • Founded
  • CLSD 2011
  • BZFD 2006
  • Country
  • CLSD United States
  • BZFD United States
  • Employees
  • CLSD N/A
  • BZFD N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • BZFD Movies/Entertainment
  • Sector
  • CLSD Health Care
  • BZFD Consumer Discretionary
  • Exchange
  • CLSD Nasdaq
  • BZFD Nasdaq
  • Market Cap
  • CLSD 69.0M
  • BZFD 76.7M
  • IPO Year
  • CLSD 2016
  • BZFD N/A
  • Fundamental
  • Price
  • CLSD $0.76
  • BZFD $2.15
  • Analyst Decision
  • CLSD Strong Buy
  • BZFD
  • Analyst Count
  • CLSD 5
  • BZFD 0
  • Target Price
  • CLSD $4.80
  • BZFD N/A
  • AVG Volume (30 Days)
  • CLSD 161.6K
  • BZFD 413.9K
  • Earning Date
  • CLSD 05-14-2025
  • BZFD 05-07-2025
  • Dividend Yield
  • CLSD N/A
  • BZFD N/A
  • EPS Growth
  • CLSD N/A
  • BZFD N/A
  • EPS
  • CLSD N/A
  • BZFD 0.34
  • Revenue
  • CLSD $3,764,000.00
  • BZFD $188,899,000.00
  • Revenue This Year
  • CLSD N/A
  • BZFD $89.62
  • Revenue Next Year
  • CLSD $476.77
  • BZFD $4.50
  • P/E Ratio
  • CLSD N/A
  • BZFD $6.39
  • Revenue Growth
  • CLSD N/A
  • BZFD N/A
  • 52 Week Low
  • CLSD $0.70
  • BZFD $1.61
  • 52 Week High
  • CLSD $1.65
  • BZFD $5.68
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 34.26
  • BZFD 54.79
  • Support Level
  • CLSD $0.77
  • BZFD $1.91
  • Resistance Level
  • CLSD $0.91
  • BZFD $2.50
  • Average True Range (ATR)
  • CLSD 0.06
  • BZFD 0.17
  • MACD
  • CLSD -0.01
  • BZFD 0.03
  • Stochastic Oscillator
  • CLSD 5.82
  • BZFD 49.28

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Share on Social Networks: